MedTrace Logo

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

NCT04798664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3228

Last updated 2026-02-25

Study results available
· View outcomes & findings →

Summary

To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Removal of Financial Barriers

Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications

BEHAVIORAL

Financial Incentives

Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.

BEHAVIORAL

Mobile Health Application

Episodic future thinking tool to overcome temporal discounting of future

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Scott D Halpern, MD PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2024-11-04
Completion
2025-04-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04798664 on ClinicalTrials.gov